Pieris Pharmaceuticals, Inc. Gains 32.01%
Tue, Jan 28, 2020 at 05:30 PM
Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ) shot up at $4, representing a gain of 32%. On Mon 27 Jan 20, PIRS:NASDAQ hit a New 2-Week Low of $3.03. From Mon 06 Jan 20, the stock recorded 35.71% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ)
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing Anticalin class of biotherapeutics for patients with diseases in which there is high unmet medical needs.
Top 10 Gainers:
- Gulf Resources, Inc. (GURE:NASDAQ), 325.84%
- Armata Pharmaceuticals, Inc. (ARMP:NYSEMKT), 73.84%
- Delphi Technologies PLC (DLPH:NYSE), 59.8%
- NantHealth, Inc. (NH:NASDAQ), 56.49%
- Acceleron Pharma Inc. (XLRN:NASDAQ), 50.16%
- Vaxart, Inc. (VXRT:NASDAQ), 37.03%
- Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ), 32.01%
- Satsuma Pharmaceuticals, Inc. (STSA:NASDAQ), 29.95%
- YayYo, Inc. (YAYO:NASDAQ), 28.18%
- Ambow Education Holding Ltd. (AMBO:NYSEMKT), 26.83%